ULTRAVIOLET SPECTROPHOTOMETRIC ANALYSIS OF DRUGS IN BIOLOGICAL FLUIDS = DOSAGE SPECTROPHOTOMETRIQUE EN ULTRAVIOLET DE MEDICAMENTS DANS LES LIQUIDES BIOLOGIQUESJATLOW P.1973; AMER. J. MED. TECHNOL.; U.S.A.; DA. 1973; VOL. 39; NO 6; PP. 231-236; BIBL. 7REF.Serial Issue

ULTRAVIOLET SPECTROPHOTOMETRY OF THEOPHYLLINE IN PLASMA IN THE PRESENCE OF BARBITURATES. = SPECTROPHOTOMETRIE UV DE LA THEOPHYLLINE DANS LE PLASMA EN PRESENCE DE BARBITURIQUESJATLOW P.1975; CLIN. CHEM.; U.S.A.; DA. 1975; VOL. 21; NO 10; PP. 1518-1520; BIBL. 11 REF.Article

Selection of analytic methods for therapeutic drug monitoringJATLOW, P.Human pathology. 1984, Vol 15, Num 5, pp 404-414, issn 0046-8177Article

INORGANIC ION COMPOSITION OF HAEMOLYMPH OF THE CECROPIA SILKMOTH: CHANGES WITH DIET AND ONTOGENY = COMPOSITION EN IONS INORGANIQUES DE L'HEMOLYMPHE DE HYALOPHORA CECROPIA: VARIATIONS LIEES AU REGIME ET A L'ONTOGENESEJUNGREIS AM; JATLOW P; WYATT GR et al.1973; J. INSECT PHYSIOL.; G.B.; DA. 1973; VOL. 19; NO 1; PP. 225-233; BIBL. 1 P. 1/2Serial Issue

SEPARATION OF URINARY AROMATIC ACIDS AND MEASUREMENT OF VANILMANDELIC ACID BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHYMOLNAR I; HORVATH C; JATLOW P et al.1978; CHROMATOGRAPHIA; DEU; DA. 1978; VOL. 11; NO 5; PP. 260-265; BIBL. 15 REF.Article

IMPROVED LIQUID-CHROMATOGRAPHIC DETERMINATION OF PROPRANOLOL IN PLASMA, WITH FLUORESCENCE DETECTIONJATLOW P; BUSH W; HOCHSTER H et al.1979; CLIN. CHEM.; USA; DA. 1979; VOL. 25; NO 5; PP. 777-779; BIBL. 17 REF.Article

KINETICS OF BILIRUBIN PHOTODEGRADATION WITH APPLICATION TO AMNIOTIC FLUIDDUBIN SB; WARDLAW S; JATLOW P et al.1980; CLIN. CHIM. ACTA; NLD; DA. 1980; VOL. 101; NO 2-3; PP. 193-207; BIBL. 28 REF.Article

DESIPRAMINE PLASMA CONCENTRATION AND ANTIDEPRESSANT RESPONSENELSON JC; JATLOW P; QUINLAN DM et al.1982; ARCHIVES OF GENERAL PSYCHIATRY; ISSN 0003-990X; USA; DA. 1982; VOL. 39; NO 12; PP. 1419-1422; BIBL. 21 REF.Article

KINETICS OF DRUG EFFECT DISTRIBUTED LAGS ANALYSIS: AN APPLICATION TO COCAINEZAHLER R; WACHTEL P; JATLOW P et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 6; PP. 775-782; BIBL. 7 REF.Article

RECURRENCE OF DEPRESSION AFTER DISCONTINUATION OF LONG-TERM AMITRIPTYLINE TREATMENTBIALOS D; GILLER E; JATLOW P et al.1982; AM. J. PSYCHIATRY; ISSN 0002-953X; USA; DA. 1982; VOL. 139; NO 3; PP. 325-329; BIBL. 17 REF.Article

INTRANASAL AND ORAL COCAINE KINETICSWILKINSON P; VANDYKE C; JATLOW P et al.1980; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1980; VOL. 27; NO 3; PP. 386-394; BIBL. 19 REF.Article

PSYCHOPHARMACOLOGY OF ATTENTION DEFICIT DISORDER: PHARMACOKINETIC, NEUROENDOCRINE, AND BEHAVIORAL MEASURES FOLLOWING ACUTE AND CHRONIC TREATMENT WITH METHYLPHENIDATESHAYWITZ SE; HUNT RD; JATLOW P et al.1982; PEDIATRICS (EVANSTON); ISSN 0031-4005; USA; DA. 1982; VOL. 69; NO 6; PP. 688-694; BIBL. 25 REF.Article

Relationships of cyclosporine concentrations in serum, whole blood, and bile after renal and hepatic transplantationVINE, W; FLYE, M. W; JATLOW, P et al.Clinical chemistry (Baltimore, Md.). 1986, Vol 32, Num 10, pp 1828-1831, issn 0009-9147Article

PLASMA COCAINE CONCENTRATIONS DURING COCAINE PASTE SMOKINGPALY D; JATLOW P; VAN DYKE C et al.1982; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1982; VOL. 30; NO 9; PP. 731-738; BIBL. 17 REF.Article

ORAL COCAINE: PLASMA CONCENTRATIONS AND CENTRAL EFFECTS.VAN DYKE C; JATLOW P; UNGERER J et al.1978; SCIENCE; USA; DA. 1978; VOL. 200; NO 4338; PP. 211-213; BIBL. 18 REF.Article

Desipramine plasma levels and response in elderly melancholic patientsCRAIG NELSON, J; JATLOW, P. I; MAZURE, C et al.Journal of clinical psychopharmacology. 1985, Vol 5, Num 4, pp 217-220, issn 0271-0749Article

CHRONIC AMITRIPTYLINE TOXICITYGILLER EL JR; BIALOS DS; DOCHERTY JP et al.1979; AMER. J. PSYCHIATRY; USA; DA. 1979; VOL. 136; NO 4A; PP. 458-459; BIBL. 8 REF.Article

Quantification of alprazolam in serum or plasma by liquid chromatographyMCCORMICK, S. R; NIELSEN, J; JATLOW, P et al.Clinical chemistry (Baltimore, Md.). 1984, Vol 30, Num 10, pp 1652-1655, issn 0009-9147Article

Differences in bioavailability between cocaine and cocaethylene and their implications for drug-reward studiesNOBILETTI, J. B; JATLOW, P. I; BRADBERRY, C. W et al.Psychopharmacologia. 1994, Vol 116, Num 3, pp 273-278, issn 0033-3158Article

Increased anxiogenic effects of caffeine in panic disordersCHARNEY, D. S; HENINGER, G. R; JATLOW, P. I et al.Archives of general psychiatry. 1985, Vol 42, Num 3, pp 233-243, issn 0003-990XArticle

Disulfiram effects on acute cocaine administrationMCCANCE-KATZ, E. F; KOSTEN, T. R; JATLOW, P et al.Drug and alcohol dependence. 1998, Vol 52, Num 1, pp 27-39, issn 0376-8716Article

Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone : A multiple-dose studyMCCANCE-KATZ, E. F; KOSTEN, T. R; JATLOW, P et al.Biological psychiatry (1969). 1998, Vol 44, Num 4, pp 250-259, issn 0006-3223Article

Rapid high-performance liquid chromatographic assay for atovaquoneHANSSON, A. G; MITCHELL, S; JATLOW, P et al.Journal of chromatography. B, Biomedical applications. 1996, Vol 675, Num 1, pp 180-182Article

Desipramine treatment of major depression in patients over 75 years of ageNELSON, J. C; MAZURE, C. M; JATLOW, P. I et al.Journal of clinical psychopharmacology. 1995, Vol 15, Num 2, pp 99-105, issn 0271-0749Article

Predictors of hospital outcome without antidepressants in major depressionMAZURE, C. M; NELSON, J. C; JATLOW, P. I et al.Psychiatry research. 1990, Vol 33, Num 1, pp 51-58, issn 0165-1781, 8 p.Article